| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.24B | +3.1% |
| Cost of Revenue | $2.18B | -3.0% |
| Gross Profit | $1.06B | +18.4% |
| R&D Expense | $98.7M | +9.3% |
| SG&A Expense | $727.4M | +4.6% |
| Operating Income | $329.3M | +67.3% |
| Pre-tax Income | $224.8M | +157.5% |
| Income Tax | $54.1M | +391.8% |
| Net Income | $169.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $399.5M | -0.1% |
| Inventory | $346.8M | -0.1% |
| Current Assets | $1.42B | +1.0% |
| Total Assets | $5.81B | -2.6% |
| Current Liabilities | $756.1M | -2.3% |
| Long-term Debt | $2.07B | -0.6% |
| Stockholders' Equity | $2.31B | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $256.8M | +27.4% |
| Capital Expenditures | $121.9M | +2.1% |
| Investing Cash Flow | -$120.6M | -28.0% |
| Financing Cash Flow | -$120.9M | +40.1% |
| Free Cash Flow | $134.9M | +64.1% |
| +123.9% |
| EPS (Basic) | $1.86 | +124.1% |
| EPS (Diluted) | $1.84 | +121.7% |